Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
12.49
+0.48 (4.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $941.00 million as of December 20, 2024. Its market cap has increased by 109.65% in one year.
Market Cap
941.00M
Enterprise Value
585.07M
1-Year Change
109.65%
Ranking
Category
Stock Price
$12.49
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $941.00M, an increase of 101.28%. That is a compound annual growth rate of 11.50%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The Pennant Group | 937.71M |
| Zymeworks | 935.36M |
| Poseida Therapeutics | 917.16M |
| Gyre Therapeutics | 914.87M |
| Nuvation Bio | 905.36M |
| Pacira BioSciences | 903.61M |
| Liquidia | 896.30M |
| Adaptive Biotechnologies | 885.48M |